# Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids

> **NCT01434524** · NA · COMPLETED · sponsor: **Kochi University** · enrollment: 56 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** LIVACT

## Key facts

- **NCT ID:** NCT01434524
- **Lead sponsor:** Kochi University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-10
- **Final completion:** 2011-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2011-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434524, "Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01434524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*